CARDIOVASCULAR THERAPEUTIC TECHNOLOGIES
CARDIOVASCULAR THERAPEUTIC TECHNOLOGIES
Industry:
Biotechnology Information Technology
Status:
Active
Similar Organizations
InTailor Surgical
InTailor Surgical develops transoral bariatric technologies.
More informations about "Cardiovascular Therapeutic Technologies"
Cardiovascular Therapeutic Technologies - Drug pipelines, Patents ...
Nov 22, 2024 Explore Cardiovascular Therapeutic Technologies with its drug pipeline, therapeutic area, technology platform, . Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last update 01 Nov 2024. Cardiovascular Therapeutic …See details»
Cardiovascular Therapeutic Technologies - Crunchbase
Organization. Cardiovascular Therapeutic Technologies . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. ... Alternatives and possible competitors …See details»
Stanford Center for Cardiovascular Technology
Cutting-Edge Diagnostic and Therapeutic Technologies The Nucleus for Cardiovascular Innovation at Stanford University ... The Stanford Center for Cardiovascular Technology, …See details»
Center for Health Technology & Innovation - American …
The AHA’s Center for Health Technology & Innovation (CHTI) spearheads innovation at the nexus of science and technology, aiming to transform the landscape of cardiovascular care and beyond. By fostering a collaborative …See details»
Cell Therapy Trials for Cardiovascular Breakthroughs
SCIRENT, a specialized cardiovascular Clinical Research Organization (CRO), stands at the forefront of this innovation. With a rich background in conducting cell therapy trials, SCIRENT brings unparalleled scientific, medical, regulatory, …See details»
Pioneering 27: Cardiac Disease Gene Therapy Firms
LEXEO is a gene therapy company that develops investigational therapies for rare monogenic diseases and diseases affecting prevalent patient populations. They utilize engineered adeno …See details»
The Top Cardiovascular CROs: A Comprehensive Ranking of …
Nov 1, 2024 Their focus on leveraging technology to improve patient experience and trial outcomes makes them a strong partner in the field of cardiovascular research. Parexel …See details»
The Future of Cardiovascular Therapeutics | Circulation
Jun 21, 2016 The use of agents targeting leaky ryanodine release channels in catecholaminergic polymorphic ventricular tachycardia is an example. 5,6 The rapid development of technologies to readily create induced pluripotent stem …See details»
Cardiovascular Therapeutic Technologies - Crunchbase
Cardiovascular Therapeutic Technologies . Connect to CRM . SaveSee details»
Cardiovascular Therapeutic Technologies Alumni Founded …
Mar 10, 2006 Cardiovascular Therapeutic Technologies. This list of organizations founded by former employees of Cardiovascular Therapeutic Technologies provides data on their funding …See details»
New strategies for treating cardiovascular disease
Feb 10, 2024 The impact of cardiovascular disease on global health. Cardiovascular disease is a major public health burden worldwide. According to the World Health Organization, they are …See details»
Cardiovascular Therapeutics - Wiley Online Library
Cardiovascular Therapeutics is an open access journal publishing original research and review articles focusing on cardiovascular and clinical pharmacology, as well as ... including rights for …See details»
Emerging Therapeutic Strategies in Cardiovascular Diseases
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS ... Innovative medical devices and technologies, such as implantable …See details»
The Imperative to Enhance Cost-Effectiveness for Cardiovascular ...
A CVOT is a large clinical trial that evaluates the effect of a therapeutic agent or intervention on clinical CV outcomes, which most often include CV death, myocardial infarction, and stroke …See details»
Utilization and Potential of RNA-Based Therapies in Cardiovascular ...
Introduction. With cardiovascular disease (CVD) remaining the largest cause of mortality worldwide, responsible for close to 18 million deaths annually (World Health Organization …See details»
New and Emerging Technology in Cardiovascular Therapeutics
The last decade has seen the introduction of a number of important technological innovations in the management of advanced cardiovascular disease. These include transcatheter aortic …See details»
A Call to Action for New Global Approaches to Cardiovascular …
Apr 20, 2021 It is estimated by the World Health Organization that 75% of the burden of cardiovascular disease across the globe is found in low- and middle-income countries. 34 …See details»
Artificial intelligence in cardiac metabolism: the next frontier in ...
1 day ago In this article, we aim to explore the rapidly developing role of artificial intelligence (AI) in cardiac metabolism research, highlighting its impact on biomarker discovery, precision …See details»
The Future of Cardiovascular Therapeutics - AHA/ASA Journals
Jun 21, 2016 the current landscape in cardiovascular drug development, and highlight therapeutic opportunities that are only now beginning to be explored. Novel approaches, from …See details»
Gene Therapy in Cardiovascular Disease: Recent Advances and …
Nov 11, 2024 Cardiovascular disease remains the foremost cause of morbidity and mortality globally, affecting millions of individuals. Recent discoveries illuminate the substantial role of …See details»